ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,052Medicare Part D Prescriptions Filled, Including Refills

Rank: 438 out of 2888

$774K Total Retail Price of All Prescriptions

Rank: 389 out of 2888

535 Patients Receiving at Least One Drug in Part D
70%Patients 65 Years and Older
72% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

19% of this provider’s 535 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

3% of this provider’s 7,518 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$70 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
METFORMIN HCL 554 369 1 8
LISINOPRIL 486 375 2 3
HYDROCODONE-ACETAMINOPHEN 483 257 S3 3 4
SIMVASTATIN 401 314 4 2
LEVOTHYROXINE SODIUM 383 306 5 1
OMEPRAZOLE 280 160 6 7
CARVEDILOL 268 219 7 21
CRESTOR 251 159 8 20
LOSARTAN POTASSIUM 249 206 9 18
ZOLPIDEM TARTRATE 222 124 10 17
TRAMADOL HCL 210 120 11 16
ATORVASTATIN CALCIUM 209 160 12 9
AMLODIPINE BESYLATE 193 159 13 5
FUROSEMIDE 190 136 14 6
PRAVASTATIN SODIUM 176 139 15 12
NEXIUM 173 101 16 19
ENALAPRIL MALEATE 148 94 17 49
JANUVIA 146 111 18 48
GLYBURIDE 140 90 R 19 58
DIOVAN 119 99 20 35
FENOFIBRATE 118 63 21 65
HYDROCHLOROTHIAZIDE 113 51 22 15
AZITHROMYCIN 105 77 23 38
ALENDRONATE SODIUM 101 94 24 23
LEVOFLOXACIN 96 71 25 57
GABAPENTIN 95 53 26 13
GLIPIZIDE 93 71 27 50
ACTOS 90 44 28 108
PANTOPRAZOLE SODIUM 89 67 29 33
METOPROLOL TARTRATE 85 57 30 10
MELOXICAM 83 64 31 31
ADVAIR DISKUS 83 49 31 60
ESCITALOPRAM OXALATE 82 52 33 62
METOPROLOL SUCCINATE 79 41 34 11
SINGULAIR 73 33 35 85
IBUPROFEN 71 55 36 87
CLOPIDOGREL 70 66 37 30
LANTUS SOLOSTAR 70 55 37 92
MIRTAZAPINE 68 56 39 54
LOVAZA 67 22 40 97
CYCLOBENZAPRINE HCL 67 23 R 40 68
TAMSULOSIN HCL 67 56 40 29
PLAVIX 64 61 43 40
CYMBALTA 63 50 44 44
DIOVAN HCT 63 52 44 61
DONEPEZIL HCL 62 52 46 26
GLYBURIDE-METFORMIN HCL 62 60 R 46 64
PREDNISONE 61 44 48 42
MONTELUKAST SODIUM 58 25 49 153
SERTRALINE HCL 56 36 50 27
NIASPAN 55 47 51 127
LISINOPRIL-HYDROCHLOROTHIAZIDE 55 49 51 28
POTASSIUM CHLORIDE 54 25 53 14
MECLIZINE HCL 50 33 54 122
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 19, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.